Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Fallopian Tube Neoplasms × Letrozole × Clear all

Phase

Status

Sponsor Class

OTHER 5 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Endometrial Neoplasms 2 Peritoneal Neoplasms 1 Fallopian Tube Neoplasms 1 Cystadenocarcinoma, Serous 1 Breast Neoplasms, Male 1 Breast Cancer Invasive Nos 1

Interventions

Paclitaxel 13 Carboplatin 13 Taxes 7 Cisplatin 6 Topotecan 3 Docetaxel 3 paclitaxel poliglumex 2 liposomal doxorubicin 2 Methods 2 Etoposide 2 Erlotinib Hydrochloride 2 Educational Status 2 Early Intervention, Educational 2 Chemotherapy, Adjuvant 2 vandetanib 1 rilotumumab 1 pegfilgrastim 1 oregovomab 1 motesanib diphosphate 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Watchful Waiting 1 VTX-2337 1 Surgical Procedures, Operative 1 Radiotherapy, Conformal 1 Psychiatric Rehabilitation 1 Polymerase Chain Reaction 1 Platinum 1 Observation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04111978 2025-09-29

MATAO

Swiss GO Trial Group

Phase 3 Recruiting

Fallopian Tube Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡